Vestor Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48K | Buy |
970
+624
| +180% | +$30.9K | ﹤0.01% | 259 |
|
|
2025
Q1 | $168K | Sell |
346
-9,390
| -96% | -$4.56M | 0.01% | 149 |
|
|
2024
Q4 | $3.92M | Buy |
9,736
+9,374
| +2,590% | +$3.78M | 0.3% | 68 |
|
|
2024
Q3 | $168K | Buy |
362
+51
| +16% | +$23.7K | 0.01% | 139 |
|
|
2024
Q2 | $146K | Buy |
311
+57
| +22% | +$26.8K | 0.01% | 149 |
|
|
2024
Q1 | $106K | Sell |
254
-2
| -0.8% | -$835 | 0.01% | 180 |
|
|
2023
Q4 | $104K | Buy |
256
+25
| +11% | +$10.2K | 0.01% | 170 |
|
|
2023
Q3 | $80K | Sell |
231
-197
| -46% | -$68.2K | 0.01% | 182 |
|
|
2023
Q2 | $151K | Buy |
428
+235
| +122% | +$82.9K | 0.02% | 142 |
|
|
2023
Q1 | $61K | Sell |
193
-18
| -9% | -$5.69K | 0.01% | 205 |
|
|
2022
Q4 | $61K | Buy |
211
+53
| +34% | +$15.3K | 0.01% | 202 |
|
|
2022
Q3 | $46K | Hold |
158
| – | – | 0.01% | 204 |
|
|
2022
Q2 | $45K | Hold |
158
| – | – | 0.01% | 202 |
|
|
2022
Q1 | $41K | Buy |
+158
| New | +$41K | ﹤0.01% | 228 |
|
|
2021
Q4 | – | Sell |
-238
| Closed | -$43K | – | 247 |
|
|
2021
Q3 | $43K | Buy |
+238
| New | +$43K | ﹤0.01% | 228 |
|